A citation-based method for searching scientific literature

Elisabeth Naderlinger, Klaus Holzmann. Genes (Basel) 2017
Times Cited: 17







List of co-cited articles
234 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
35

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
124
35

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
221
35

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
565
35


Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Jau-Yu Liau, Jia-Huei Tsai, Ching-Yao Yang, Jen-Chieh Lee, Cher-Wei Liang, Hung-Han Hsu, Yung-Ming Jeng. Hum Pathol 2015
30
29

Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Gary A Ulaner, Hsuan-Ying Huang, Jesse Otero, Zhiquan Zhao, Leah Ben-Porat, Jaya M Satagopan, Richard Gorlick, Paul Meyers, John H Healey, Andrew G Huvos,[...]. Cancer Res 2003
135
29

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
626
29

The C-Circle Assay for alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Loretta M Lau, Sylvia Koch, Nancy Martin La Rotta, Rebecca A Dagg, Roger R Reddel. Methods 2017
50
29

Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
497
29

Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
Aurora Costa, Maria Grazia Daidone, Laura Daprai, Raffaella Villa, Sabrina Cantù, Silvana Pilotti, Luigi Mariani, Alessandro Gronchi, Jeremy D Henson, Roger R Reddel,[...]. Cancer Res 2006
97
29

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
282
29

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
29

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
29

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
207
29

Telomere Maintenance Mechanisms in Cancer.
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares, João Vinagre. Genes (Basel) 2018
46
29


Alternative lengthening of telomeres as a prognostic factor in malignant fibrous histiocytomas of bone.
Toshihiro Matsuo, Shoji Shimose, Tadahiko Kubo, Jun Fujimori, Yuji Yasunaga, Mitsuo Ochi. Anticancer Res 2010
12
33



Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome.
Jau-Yu Liau, Jia-Huei Tsai, Yung-Ming Jeng, Jen-Chieh Lee, Hung-Han Hsu, Ching-Yao Yang. Am J Surg Pathol 2015
52
23

Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis.
Lorenza Venturini, Rosita Motta, Alessandro Gronchi, MariaGrazia Daidone, Nadia Zaffaroni. BMC Cancer 2010
27
23

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
344
23

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Ke Gao, Gang Li, Yiping Qu, Maode Wang, Bo Cui, Meiju Ji, Bingyin Shi, Peng Hou. Oncotarget 2016
41
23

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
273
23

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
515
23



Telomerase expression predicts unfavorable outcome in osteosarcoma.
Robert P Sanders, Rachid Drissi, Catherine A Billups, Najat C Daw, Marcus B Valentine, Jeffrey S Dome. J Clin Oncol 2004
69
23

MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising.
Francesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, Nadia Zaffaroni, Marco Folini. Curr Pharm Des 2014
13
30

Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival.
Kerrie L McDonald, Julie McDonnell, Alessandra Muntoni, Jeremy D Henson, Monika E Hegi, Andreas von Deimling, Helen R Wheeler, Ray J Cook, Michael T Biggs, Nicholas S Little,[...]. J Neuropathol Exp Neurol 2010
62
17

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Joshua Mangerel, Aryeh Price, Pedro Castelo-Branco, Jack Brzezinski, Pawel Buczkowicz, Patricia Rakopoulos, Diana Merino, Berivan Baskin, Jonathan Wasserman, Matthew Mistry,[...]. Acta Neuropathol 2014
27
17

Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jennie N Jeyapalan, Aaron Mendez-Bermudez, Nadia Zaffaroni, Yuri E Dubrova, Nicola J Royle. Int J Cancer 2008
40
17

Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors.
Christopher J VandenBussche, Derek B Allison, Mindy K Graham, Vivek Charu, Anne Marie Lennon, Christopher L Wolfgang, Ralph H Hruban, Christopher M Heaphy. Cancer Cytopathol 2017
25
17

Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends.
Claus M Azzalin, Patrick Reichenbach, Lela Khoriauli, Elena Giulotto, Joachim Lingner. Science 2007
813
17

Telomerase Regulation from Beginning to the End.
Deanna Elise MacNeil, Hélène Jeanne Bensoussan, Chantal Autexier. Genes (Basel) 2016
47
17

Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres.
Rebecca A Dagg, Hilda A Pickett, Axel A Neumann, Christine E Napier, Jeremy D Henson, Erdahl T Teber, Jonathan W Arthur, C Patrick Reynolds, Jayne Murray, Michelle Haber,[...]. Cell Rep 2017
35
17

Alternative lengthening of telomeres does exist in various canine sarcomas.
Theresa Kreilmeier, Sandra Sampl, Abigail J Deloria, Ingrid Walter, Martin Reifinger, Marlene Hauck, Luke B Borst, Klaus Holzmann, Miriam Kleiter. Mol Carcinog 2017
6
50

Break-induced telomere synthesis underlies alternative telomere maintenance.
Robert L Dilley, Priyanka Verma, Nam Woo Cho, Harrison D Winters, Anne R Wondisford, Roger A Greenberg. Nature 2016
200
17


Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.
V Hakin-Smith, D A Jellinek, D Levy, T Carroll, M Teo, W R Timperley, M J McKay, R R Reddel, J A Royds. Lancet 2003
205
17

miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.
Graziella Cimino-Reale, Paolo Gandellini, Francesca Santambrogio, Marta Recagni, Nadia Zaffaroni, Marco Folini. J Hematol Oncol 2017
14
21

Telomere elongation in immortal human cells without detectable telomerase activity.
T M Bryan, A Englezou, J Gupta, S Bacchetti, R R Reddel. EMBO J 1995
980
17

Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.
Yu-Jen Chen, Vicky Hakin-Smith, Mario Teo, George E Xinarianos, David A Jellinek, Thomas Carroll, David McDowell, Martin R MacFarlane, Ronald Boet, Bruce C Baguley,[...]. Cancer Res 2006
55
17

TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma.
Hong Xie, Tiantian Liu, Na Wang, Viveca Björnhagen, Anders Höög, Catharina Larsson, Weng-Onn Lui, Dawei Xu. Oncotarget 2014
40
17

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
148
17

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
73
17

Telomerase catalytic subunit homologs from fission yeast and human.
T M Nakamura, G B Morin, K B Chapman, S L Weinrich, W H Andrews, J Lingner, C B Harley, T R Cech. Science 1997
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.